ESTRELLA IMMUNOPHARMA, INC. (ESLAW) | Jive Data

Google Sheets Add-onSheets Account

Profile Financials SEC Filings Insider Transactions Ownership

Loading ESLAW…

ESTRELLA IMMUNOPHARMA, INC. (ESLAW) | Jive Data

Google Sheets Add-onSheets Account

Profile Financials SEC Filings Insider Transactions Ownership

SEC filing

ESTRELLA IMMUNOPHARMA, INC.

ESLAW · CIK 1844417

4 · Aug 25, 2026 · Chief Financial Officer Xu Jiandong exercised options for 200K shares

4

Chief Financial Officer Xu Jiandong exercised options for 200K shares

Filed: Aug 25, 2026
Period: Aug 18, 2026
Accession: 0001213900-26-093698
Filer: Estrella Immunopharma, Inc.

View on SEC.gov All SEC filings

Filing document

xslF345X06/ownership.xml

xslF345X06/ownership.xmlSEC.gov

Other files

Graphics and non-inline formats (not embedded below).

4ownership.xml
Open SEC.gov